These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9673589)
1. The 1st European Conference on the Economics of Cancer. Brussels, 19-21 November 1997. Abstracts. Eur J Cancer; 1997 Nov; 33 Suppl 9():S1-40. PubMed ID: 9673589 [No Abstract] [Full Text] [Related]
2. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook. J Natl Cancer Inst Monogr; 1998; (24):1-28. PubMed ID: 9704318 [No Abstract] [Full Text] [Related]
3. [Oncology caught between economics and efficiency]. Keil TU Med Klin (Munich); 2000 Jun; 95 Suppl 1():1. PubMed ID: 10941245 [No Abstract] [Full Text] [Related]
4. [Cancer and health economics]. Koinuma N Gan To Kagaku Ryoho; 1996 Jan; 23(1):1-7. PubMed ID: 8546457 [TBL] [Abstract][Full Text] [Related]
5. 2nd European Conference on the Economics of Cancer. Brussels, 3-5 September 2000. Abstracts. Eur J Cancer; 2000 Aug; 36 Suppl 3():S1-28. PubMed ID: 11086466 [No Abstract] [Full Text] [Related]
6. Counting the costs of cancer care. Lyman GH Lancet Oncol; 2013 Nov; 14(12):1142-3. PubMed ID: 24131613 [No Abstract] [Full Text] [Related]
8. The cost of treating cancer patients: treatments versus reimbursements. Goldstein MG Md Med; 2011; 12(4):15. PubMed ID: 22455202 [No Abstract] [Full Text] [Related]
9. The war on cancer: progress at what price? Konski A J Clin Oncol; 2011 Apr; 29(12):1503-4. PubMed ID: 21402613 [No Abstract] [Full Text] [Related]
10. Cost of cancer care: issues and implications. Meropol NJ; Schulman KA J Clin Oncol; 2007 Jan; 25(2):180-6. PubMed ID: 17210937 [TBL] [Abstract][Full Text] [Related]
11. Advanced APMs and the emerging role of immuno-oncology agents: balancing innovation and value. Seiden MV; Neubauer M; Verrilli D Am J Manag Care; 2017 Feb; 23(2 Spec No.):SP69-SP77. PubMed ID: 28298130 [No Abstract] [Full Text] [Related]
12. Value in Oncology: Balance Between Quality and Cost. Raghavan D; Legnini MW Am Soc Clin Oncol Educ Book; 2016; 35():9-13. PubMed ID: 27249680 [No Abstract] [Full Text] [Related]
13. User beware: we need more science and less art when measuring financial toxicity in oncology. de Souza JA; Yap B; Ratain MJ; Daugherty C J Clin Oncol; 2015 Apr; 33(12):1414-5. PubMed ID: 25732158 [No Abstract] [Full Text] [Related]
15. Reply to J.A. de Souza et al. Khera N J Clin Oncol; 2015 Apr; 33(12):1415-6. PubMed ID: 25732169 [No Abstract] [Full Text] [Related]
16. Is high and growing spending on cancer treatment and prevention harmful to the United States economy? Pauly MV J Clin Oncol; 2007 Jan; 25(2):171-4. PubMed ID: 17210935 [No Abstract] [Full Text] [Related]
17. Can we afford the war on cancer? Szucs TD Onkologie; 2008 Mar; 31(3):81. PubMed ID: 18322408 [No Abstract] [Full Text] [Related]
18. [The economic burden of cancer and the access to innovation should boost the use of real world data]. Thierry JP Bull Cancer; 2017 Jun; 104(6):495-496. PubMed ID: 28578773 [No Abstract] [Full Text] [Related]
19. Affordable oncologic care: a challenging goal. Barton MK CA Cancer J Clin; 2014; 64(2):75-8. PubMed ID: 24420975 [No Abstract] [Full Text] [Related]
20. Not at any cost: organizations help patients cope with costs of cancer care. Printz C Cancer; 2011 Mar; 117(5):879. PubMed ID: 21351079 [No Abstract] [Full Text] [Related] [Next] [New Search]